---
figid: PMC6468893__toxins-11-00167-g010
figtitle: Dual prey-inactivation strategy of the venom of C
organisms:
- Cupiennius salei
- Drosophila melanogaster
- Bombyx mori
- Apis mellifera
- Ixodes scapularis
- Tetranychus urticae
- Pleocyemata sp.
- Rhipicephalus microplus
- Ixodes ricinus
- Amblyomma americanum
- Limulus polyphemus
- Rhipicephalus sanguineus
- Parasteatoda tepidariorum
- Tachypleus tridentatus
- Phoneutria nigriventer
- Latrodectus hesperus
- Mesobuthus martensii
- Amblyomma cajennense
- Tityus serrulatus
- Sagmariasus verreauxi
- Xibalbanus tulumensis
- Amblyomma triste
- Cyriopagopus schmidti
- Stegodyphus mimosarum
- Conus marmoreus
- Hadogenes troglodytes
- Amblyomma parvum
- Nephila pilipes
- Conus textile
- Simulium vittatum
- Androctonus bicolor
- RTA clade
- Amilenus aurantiacus
- Tityus obscurus
- Atypus piceus
- Trittame loki
- Isometroides vescus
- Lychas buchari
- Hadrurus spadix
- Dolomedes fimbriatus
- Hadronyche infensa
- Eratigena atrica
- Megacormus gertschi
- Viridasius fasciatus
- Oxyopes heterophthalmus
- Alopecosa marikovskyi
- Ancylometes rufus
- Cupiennius getazi
- Tegenaria atrica
- Haplopelma hainanum
- Macrothele gigas
- Brachypelma vagans
- Phoneutria reidyi
- Tenebrio obscurus
- Agelena orientalis
- Superstitionia donensis
- Oxyopes lineatus
- Lachesana tarabaevi
- Lycosa singoriensis
- Tityus bahiensis
- Synsphyronus apimelus
- Cheiracanthium punctorium
- Atrax robustus
- Hadronyche versuta
- Agelenopsis aperta
- Latrodectus tredecimguttatus
- Polybetes pythagoricus
- Centruroides hentzi
- Xysticus cristatus
- Gallus gallus
- Calloplesiops altivelis
- Naja kaouthia
- Dendroaspis polylepis polylepis
- Bombina maxima
- Draco fimbriatus
- Solanum tuberosum
- Aspergillus niger
- Manihot esculenta
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Wisteria badnavirus 1
- NA
pmcid: PMC6468893
filename: toxins-11-00167-g010.jpg
figlink: /pmc/articles/PMC6468893/figure/toxins-11-00167-f010/
number: F10
caption: Dual prey-inactivation strategy of the venom of C. salei based on specific
  (left) and unspecific (right) venom pathways. Main interactions of the major venom
  components are shown in the venom gland (upper half) and, after venom injection,
  in the target organism (lower half). The specific pathway, mainly based on neurotoxins
  and other compounds, usually leads to death. The unspecific or metabolic pathway,
  based on a variety of regulatory elements, disturbs homeostasis or leads to hyperglycemia.
  The thickness of the gray arrows indicates the estimated impact on the prey. Dashed
  lines represent vague or uninvestigated connections (for further details compare
  text). ACE, angiotensin-converting enzyme; CRISPs, Cysteine-rich secretory proteins;
  CST, cystatin; CsTx, Cupiennius salei toxins; HYAL, hyaluronidase; IGFBP-rP1, insulin-like
  growth factor-binding protein-related protein 1; KCP, Kunitz domain-containing protein;
  LRR, leucine-rich repeat domain-containing protein; PAM, peptidylglycine α-amidating
  monooxygenase; PDI, protein disulfide isomerase; PLA2, phospholipase A2; SMMC, small
  molecular mass compounds; TL5A, tachylectin 5A-like protein; TT1LP, thyroglobulin
  type-1 domain-like protein.
papertitle: The Dual Prey-Inactivation Strategy of Spiders—In-Depth Venomic Analysis
  of Cupiennius salei.
reftext: Lucia Kuhn-Nentwig, et al. Toxins (Basel). 2019 Mar;11(3):167.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9123756
figid_alias: PMC6468893__F10
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Gallus gallus
- Bombyx mori
redirect_from: /figures/PMC6468893__F10
ndex: bd0324e9-df0d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6468893__toxins-11-00167-g010.html
  '@type': Dataset
  description: Dual prey-inactivation strategy of the venom of C. salei based on specific
    (left) and unspecific (right) venom pathways. Main interactions of the major venom
    components are shown in the venom gland (upper half) and, after venom injection,
    in the target organism (lower half). The specific pathway, mainly based on neurotoxins
    and other compounds, usually leads to death. The unspecific or metabolic pathway,
    based on a variety of regulatory elements, disturbs homeostasis or leads to hyperglycemia.
    The thickness of the gray arrows indicates the estimated impact on the prey. Dashed
    lines represent vague or uninvestigated connections (for further details compare
    text). ACE, angiotensin-converting enzyme; CRISPs, Cysteine-rich secretory proteins;
    CST, cystatin; CsTx, Cupiennius salei toxins; HYAL, hyaluronidase; IGFBP-rP1,
    insulin-like growth factor-binding protein-related protein 1; KCP, Kunitz domain-containing
    protein; LRR, leucine-rich repeat domain-containing protein; PAM, peptidylglycine
    α-amidating monooxygenase; PDI, protein disulfide isomerase; PLA2, phospholipase
    A2; SMMC, small molecular mass compounds; TL5A, tachylectin 5A-like protein; TT1LP,
    thyroglobulin type-1 domain-like protein.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRR
  - Def
  - Pdi
  - cst
  - CG42237
  - Ace
  - Acer
  - Ance
  - pain
  - term
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - gish
  - KCP
  - OMA1
  - PAM
  - MYCBP2
  - P4HB
  - PADI1
  - PDIA2
  - GAL3ST1
  - SLC35A1
  - CASZ1
  - CST12P
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - IGFBP7
  - PLA2G1B
  - PLA2G2A
  - PLA2G6
  - PLA2G3
  - PLA2G5
  - PLA2G7
  - PLA2G10
  - PLA2G12A
  - PLA2G12B
  - PLA2G2C
  - PLA2G2D
  - PLA2G2E
  - PLA2G2F
  - PLA2G4A
  - PLA2G4C
  - PLA2G4D
  - ACE
  - Kcp
  - Pam
  - Mycbp2
  - Pdia3
  - P4hb
  - Padi2
  - Cort
  - Slc35a1
  - Gal3st1
  - Casz1
  - Pla2g2a
  - Pla2g5
  - Defensin
  - ace2
  - Defensin
  - paralysis
  - convulsions
  - pain
  - inflammation
  - hyperglycemia  I disorder
---
